Detalhe da pesquisa
1.
Anti-Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.
Transpl Infect Dis
; 18(3): 354-60, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26998687
2.
Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management.
Ann Oncol
; 19(5): 984-9, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18227109
3.
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
Leukemia
; 21(6): 1294-9, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17377586
4.
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.
Leukemia
; 32(2): 383-390, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28761118
5.
Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures.
Ann Oncol
; 18(11): 1870-4, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17804478
6.
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.
Bone Marrow Transplant
; 39(7): 389-96, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17310135
7.
Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients.
Int J Hematol
; 86(2): 158-62, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875531
8.
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.
Leukemia
; 31(4): 889-895, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27774990
9.
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.
Leuk Lymphoma
; 47(1): 59-63, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16321828
10.
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.
Leukemia
; 29(8): 1721-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25787915
11.
A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study.
Bone Marrow Transplant
; 25 Suppl 2: S27-31, 2000 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-10933183
12.
New strategies in the treatment of graft-versus-host disease.
Bone Marrow Transplant
; 25 Suppl 2: S12-5, 2000 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-10933179
13.
Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.
Bone Marrow Transplant
; 25(4): 371-6, 2000 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-10723579
14.
Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
Bone Marrow Transplant
; 25(1): 41-5, 2000 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-10654013
15.
A second unrelated bone marrow transplant with an unrelated donor marrow: treatment of a patient with relapsed leukemia.
Bone Marrow Transplant
; 21(3): 291-3, 1998 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-9489653
16.
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study.
Bone Marrow Transplant
; 27(1): 27-33, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11244435
17.
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.
Bone Marrow Transplant
; 25 Suppl 2: S6-8, 2000 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-10933177
18.
Chronic eosinophilic leukemia: successful treatment with an unrelated bone marrow transplantation.
Leuk Lymphoma
; 32(1-2): 189-93, 1998 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-10037016
19.
Mycophenolate mofetil in stem cell transplant patients in relation to plasma level of active metabolite.
Clin Biochem
; 33(3): 203-8, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10913519
20.
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial.
Bone Marrow Transplant
; 52(8): 1194-1198, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28504661